Skip to main content

2023 Program

Loading
12:00 PM
  1. Yosemite Foyer
    300 mins
1:30 PM
  1. 240 mins
    On the afternoon of October 16th, BIO will present the first BIO Seed-Stage Spotlight on Tech Transfer, featuring more than two dozen exciting early-stage companies giving brief pitches and getting in ...
5:30 PM
  1. Grand Ballroom
    60 mins
    Attendees of the BIO Seed-Stage Spotlight on Tech Transfer are invited to join us for a reception to cap off the day of presentations.
6:30 AM
  1. Yosemite Foyer
    630 mins
7:30 AM
  1. Grand Ballroom
    600 mins
9:00 AM
  1. Franciscan B/C/D
    180 mins

    Attend 13-minute presentations across several therapeutic areas.
     

9:45 AM
  1. Franciscan C
    15 mins
    • Oncology
    Diakonos Oncology is a clinical-stage biotechnology company, developing a novel "Double-Loaded" Dendritic Cell Vaccine (DCV) for the treatment of Glioblastoma Multiforme (GBM) as well as other difficu ...
  2. Franciscan D
    15 mins
    • Diagnostics
    Company Description: Craif has developed a miRNA platform and proprietary sampling technology that allows the capture of lower expression RNA in order to develop assays that can accurately predict a p ...
10:00 AM
  1. Imperial Ballroom
    50 mins
    With bank failures and volatile markets this year, it is more important than ever for early-stage companies to demonstrate their distinct strengths as investors evaluate their priorities. Attend this ...
  2. Franciscan C
    15 mins
    • Oncology
    Panavance Therapeutics Inc. is a privately-held, clinical-stage pharmaceutical company developing a novel oncology platform focused on improving the outcomes and quality of life for patients. Panavanc ...
  3. Franciscan D
    15 mins
    • Diagnostics
    Company Description: Imagion Biosystems, Ltd. (ASX: IBX) is pioneering molecularly targeted MRI Contrast Agents with its MagSense® technology - a new functional imaging product line that holds the pr ...
  4. Franciscan B
    15 mins
    • Dermatology
    Company Description: NOxy Health Products is a healthcare company driven to developing innovative medicines that harness the natural restorative power of nitric oxide (NO) to heal chronic wounds. NOxy ...
10:15 AM
  1. Franciscan D
    15 mins
    • Regenerative Medicine
    Biotech developing mRNA therapeutics to combat aging and age-related disease
  2. Franciscan C
    15 mins
    • Oncology
    Pacylex Pharmaceuticals is a Canadian oncology company in Phase 2 with a highly differentiated cancer therapy, zelenirstat (PCLX-001), a first in class, once-per-day oral medication that completely re ...
  3. Franciscan B
    15 mins
    • Oncology
    Company Description: Estrigenix Therapeutics is preclinical pharmaceutical development company pioneering therapies to improving women's health. Estrigenix was formed as a spinout of collaborative res ...
10:30 AM
  1. Franciscan C
    15 mins
    • Oncology
    Osmol is an IND-stage biopharma company based in New Haven, CT, developing technology licensed from Yale School of Medicine to address chemotherapy induced peripheral neuropathy (CIPN). CIPN is a sign ...
  2. Franciscan B
    15 mins
    • Oncology
    ZWI Therapeutics is a biotechnology company developing novel protein therapeutics linked to a novel polymer. The company's proprietary polymer technology reduces the immunogenicity of therapeutic prot ...
  3. Franciscan D
    15 mins
    • Oncology
    Aptah's molecule is the first and only compound that assures accurate RNA processing of multiple proteins. It works as a template for overall RNA quality control, altering the fate of diseased cells w ...
10:45 AM
  1. Franciscan B
    15 mins
    • Dermatology
    Company Description: NFlection is a clinical stage biopharmaceutical company focused on the development of novel therapies to address the needs of patients with neurofibromatosis type 1, immunosuppres ...
  2. Franciscan D
    15 mins
    • Reproductive/Sexual Health
    Maipl has created an exceptionally potent small molecule prostaglandin PGF2α antagonist, MA-7107, that has exquisite selectivity, without interfering other essential prostaglandin functions. High lev ...
11:00 AM
  1. Imperial Ballroom
    50 mins
    The ability of bispecific antibodies and antibody drug conjugates to interact with two biologic binding sites at once creates major leverage for interfering with a disease mechanism intercellularly as ...
  2. Franciscan D
    15 mins
    • Pain Management
    Sustained Therapeutics is a clinical stage company developing a drug delivery platform technology initially focused on non-opioid pain medication, but extendable to other APIs including significant on ...
  3. Franciscan C
    15 mins
    • Oncology
    LBL Biotec. Inc. is a spin-off company from National Cheng-kung University at Taiwan. The company focusses on the development of IL-20 antibody to treat several inflammation-associated diseases such a ...
  4. Franciscan B
    15 mins
    • Dermatology
    Company Description: Shaperon Inc. is a clinical stage biotech company (KOSDAQ Ticker: 378800). It has 3 clinical stage assets. (1) Atopic Dermatitis: US FDA IND approval in September 2023. With its e ...
11:15 AM
  1. Franciscan D
    15 mins
    • Pain Management
    South Rampart Pharma, Inc. is a clinical-stage biotech company focused on addressing the critical need for a safe and effective approach to relieving pain. Its lead clinical candidate, SRP-001, is a n ...
  2. Franciscan C
    15 mins
    • Oncology
    Multimeric Biotherapeutics, Inc. is an early-stage, founder-backed company focused on stimulating immunity against cancer and infections. Its patented FortiVac technology elicits very strong CD8+ T ce ...
  3. Franciscan B
    15 mins
    • Gastrointestinal
    Company Description: First Wave BioPharma, Inc. is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. Fi ...
11:30 AM
  1. Franciscan C
    15 mins
    • Oncology
    Enzyme by Design is a preclinical stage biotech startup specializing in engineering highly effective and significantly safer cancer biologics.
  2. Franciscan B
    15 mins
    • Tools/Drug Development Support Tech
    Company Description: GATC Health is an AI company transforming drug development and disease prediction. Our proprietary Multiomics Advanced Technologyâ„¢ (MAT) simulates complex human physiology for t ...
  3. Franciscan D
    15 mins
    • Pain Management
    DIMERx is a platform company progressing an oral, non-addictive opioid analgesic for chronic pain through mid/late-stage clinical trials. DIMERx is developing DMX-101, a dimer of buprenorphine, for th ...
11:45 AM
  1. Franciscan B
    15 mins
    • Tools/Drug Development Support Tech
    Company Description: Acoustic Bio is a Stanford University spin-out company focused on developing a platform to scale and accelerate screening of patient-derived organoids (PDOs) to advance personaliz ...
  2. Franciscan D
    15 mins
    • Pain Management
    Company Description: Rebel Medicine is a specialty pharmaceutical company headquartered in Salt Lake City, Utah, that leverages drug delivery science to create innovative therapies to address unmet me ...
  3. Franciscan C
    15 mins
    • Oncology
    Company Description: Orphagen is a pioneer in discovery and development of small molecule drugs that modulate orphan or unexplored members of the nuclear receptor family, one of the most successful dr ...
12:00 PM
  1. Grand Ballroom
    60 mins
1:00 PM
  1. Franciscan B/C/D
    240 mins
    Attend 13-minute presentations across several therapeutic areas.
  2. Imperial Ballroom
    50 mins
    More than 130 human health companies are in SOSV's portfolio, and more than 30 of those are pre-series-A biopharma start-ups in IndieBio's program. Mohan Iyer is a General Partner at SOSV's IndieBio S ...
1:15 PM
  1. Franciscan C
    15 mins
    • Oncology
    Kineta is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients' lives. Kineta has leveraged its expertise in innate immunity and is ...
  2. Franciscan B
    15 mins
    • Immunology
    EYAM is a platform biotech company with strong animal efficacy data for an AI-informed self-amplifying RNA/DNA smart vector. We are seeking investment and strategic partnership opportunities. At Eyam, ...
  3. Franciscan D
    15 mins
    • CNS/Neurological
    OYE is a clinical stage pharmaceutical company focused on a late stage, low risk 505(b)2 opportunity that has already achieved market adoption and uptake in the hospital market.
1:30 PM
  1. Franciscan B
    15 mins
    • Infectious Diseases
    Protalix is a commercial stage biopharmaceutical company focused on the development and commercialization of proprietary recombinant therapeutic proteins that target rare genetic diseases with unmet m ...
  2. Franciscan D
    15 mins
    • CNS/Neurological
    Panorama Medicine is a world-leading drug developer in RNA splicing. Our AI-driven platform allows us to explore the vast, untapped RNA space for new modality discovery. We have built a pipeline with ...
  3. Franciscan C
    15 mins
    • Oncology
    Company Description: Cytovation is a clinical-stage immuno-oncology biotech focused on the development of CyPep-1, a first-in-class synthetic peptide that has been designed to selectively target cance ...
1:45 PM
  1. Franciscan B
    15 mins
    • Infectious Diseases
    Company Description: Antisense Therapeutics Limited (ASX: ANP; OTC: ATHJY) is an Australian biotechnology company focused on rare diseases. Through a partnership with Ionis Pharmaceuticals (NASDAQ: IO ...
  2. Franciscan D
    15 mins
    • CNS/Neurological
    Company Description: Finding new therapies for brain diseases requires preclinical models and assays with increased clinical relevance. a:head aims to develop a human-based platform for generating com ...
  3. Franciscan C
    15 mins
    • Oncology
    Company Description: Yinuoke is a biotech company developing First-in-Concept therapies for cancer patients who have exhausted available therapies based on a deep and unique understanding of cancer bi ...
2:00 PM
  1. Imperial Ballroom
    50 mins
    With the majority of biological studies conducted in academic settings but nearly all innovative new drug clinical trials sponsored by industry, improving translational research success rates for comm ...
  2. Franciscan C
    15 mins
    • Oncology
    Company Description: Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug D ...
  3. Franciscan D
    15 mins
    • CNS/Neurological
    Company Description: Jaya Biosciences (Jaya) is developing targeted gene therapies for impaired lysosome/autophagy function, a critical component in the etiology of severe neurodegenerative diseases, ...
  4. Franciscan B
    15 mins
    • Infectious Diseases
    Company Description: RS BioTherapeutics (RSBT) is developing a pharmaceutical compound for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other diseases characterized by pulmonary inflammati ...
2:15 PM
  1. Franciscan B
    15 mins
    • Infectious Diseases
    Lactiga is an award-winning, visionary biotechnology company committed to pushing the boundaries of medical science and improving the lives of immunodeficient patients through innovative mucosal thera ...
  2. Franciscan C
    15 mins
    • Oncology
    Company Description: Welton Pharma is pre-clinical company developing our lead asset WP-038 for the treatment of colorectal cancer. Our patent-protected drug product is expected to increase the respon ...
  3. Franciscan D
    15 mins
    • CNS/Neurological
    Company Description: Ilios Therapeutics is a biopharmaceutical company discovering and developing rationally-designed multi-targeted therapeutics to combat neurodegenerative diseases. Our innovative c ...
2:30 PM
  1. Franciscan B
    15 mins
    • Infectious Diseases
    Sarcomatrix is a preclinical stage biopharma developing novel therapeutics and enabling technologies across multiple indications; starting with muscle wasting diseases and muscular dystrophies.
  2. Franciscan D
    15 mins
    • CNS/Neurological
    EpiVario Inc. is pioneering epigenetic therapeutic development to redefine treatment landscapes for neuropsychiatric disorders. Spun out of the Epigenetics Institute at the University of Pennsylvania, ...
  3. Franciscan C
    15 mins
    • Oncology
    Company Description: Amberstone Biosciences is developing a new class of paradigm-shifting, Tumor Microenvironment Activated ThErapeutic (“T-MATEâ€') antibodies and cytokines that can offer signific ...
2:45 PM
  1. Franciscan D
    15 mins
    • CNS/Neurological
    Clinical stage drug company engineering drug combinations to accelerate neuroplasticity (brain's capacity to rebuild, rewire, and repair). Target patients are those suffering brain injuries, deteriora ...
  2. Franciscan C
    15 mins
    • Oncology
    Company Description: VerImmune Inc (www.verimmune.com) is developing a highly innovative Virus-inspired Particle (ViPâ„¢) platform technology that has the potential to treat multiple diseases. VerImmu ...
  3. Franciscan B
    15 mins
    • Oncology
    Company Description: A multi-indication, radiosensitizing platform to increase the effectiveness of radiotherapy and immunotherapy.
3:00 PM
  1. Franciscan D
    15 mins
    • Platform for Therapeutics
    Macrobiome Therapeutics Pty Ltd is a company harnessing the therapeutic potential of hookworms and other parasitic helminths to develop drugs for the treatment of chronic wounds and autoimmune and met ...
  2. Imperial Ballroom
    50 mins
    Within the past five years, RNA technologies have demonstrated they can improve patients' health by transforming gene expression and open a successful new frontier for infectious disease vaccine devel ...
  3. Franciscan C
    15 mins
    • Oncology
    Company Description: Kernal Bio is a biotech company developing mRNA 2.0 immunotherapies. Kernal mines translatome data to discover cell-specific sequence features and design mRNAs that are selectivel ...
  4. Franciscan B
    15 mins
    • Metabolic Diseases
    Company Description: Mitotech Ltd is a UK-based clinical stage biotechnology company developing mitochondria targeted drugs for a variety of neurodegenerative and metabolic diseases such as Obesity, N ...
3:15 PM
  1. Franciscan D
    15 mins
    • Platform for Therapeutics
    Algen is a platform therapeutics and drug discovery company using the world's leading CRISPR and AI to uncover disease-driving RNA messages to find treatments for cancer, inflammation and other diseas ...
  2. Franciscan C
    15 mins
    • Oncology
    Company Description: Degron Therapeutics is a preclinical-stage biotech dedicated to the discovery and development of a new class of targeted protein degradation therapeutics – small molecule molecu ...
  3. Franciscan B
    15 mins
    • Multiple Therapeutics
    Company Description: Sonata Therapeutics is creating a new class of therapeutics called network medicines. These are the first therapeutics designed specifically to reprogram diseased cells in order t ...
3:30 PM
  1. Franciscan C
    15 mins
    • Oncology
    Company Description: Each year, an investment of $50 to $60 billion is directed towards oncology clinical trials, only to face an alarming 90% failure rate. The elevated failure rate largely stems fro ...
  2. Franciscan D
    15 mins
    • Platform for Therapeutics
    Company Description: Aperture Therapeutics is a pre-clinical stage drug discovery company developing novel therapeutics to modulate neuroinflammation in age-related neurodegenerative disorders. The co ...
  3. Franciscan B
    15 mins
    • Tools/Drug Development Support Tech
    Company Description: Synvivia optimizes cells for gene therapy manufacturing. Our technology increases gene therapy yield and potency by 3-10X, with thousands of improvements in the pipeline. Our prod ...
3:45 PM
  1. Franciscan C
    15 mins
    • Oncology
    Private pre-clinical Biotech developing novel small molecules for multiple solid tumors
  2. Franciscan B
    15 mins
    • Multiple Therapeutics
    Proven, clinical stage company discovering and developing first-in-class kinase inhibitors for diseases of the liver, kidney, and CNS. Lead program is phase 2-ready and will be evaluated in liver and/ ...
  3. Franciscan D
    15 mins
    • Platform for Therapeutics
    Company Description: Farcast's mission is to improve predictability in cancer treatment. Farcast's Human Tumor Microdynamics (hTMD) platform generates and mines“tumor response big dataâ€' by uniquel ...
4:00 PM
  1. Imperial Ballroom
    50 mins
    A recent article noted that the APAC biotech market is estimated to expand at a rapid compound annual growth rate of 16.8 percent up to 2028. With some of the world's most populous countries, the need ...
  2. Franciscan C
    15 mins
    • Oncology
    Synlico Inc. envisions rewriting medicine by bringing causality to cellular biology. As an AI-powered drug discovery biotech company, our primary mission is to develop cutting-edge engineered T cell t ...
  3. Franciscan D
    15 mins
    • Platform for Therapeutics
    Company Description: Kapoose Creek Bio is a Canadian biotech company using AI technologies to uncover small molecule medicines from nature with unprecedented speed and scale. Our R&D efforts are suppo ...
  4. Franciscan B
    15 mins
    • Multiple Therapeutics
    Company Description: Inimmune is harnessing the human immune system to create next generation immunotherapeutics for the treatment of allergy, infectious disease, autoimmunity, opioid addiction and ca ...
4:15 PM
  1. Franciscan D
    15 mins
    • Platform for Therapeutics
    Commercializing the human Trophoblast Stem Cell Platform for Cell and Gene Therapy
  2. Franciscan C
    15 mins
    • Oncology
    Company Description: YDS Pharmatech, Inc. is heading for next-generation induced-proximity drug discovery. Using our AI+biophysics simulation combined with proteomics technologies to advance the disco ...
  3. Franciscan B
    15 mins
    • Multiple Therapeutics
    Company Description: Caledon Bioscience is a newly formed, privately held, spin-out. We are a development stage biopharmaceutical company focused on discovering and developing novel and distinctive sm ...
5:30 PM
  1. 60 mins
    Join your fellow attendees for a networking reception to close out Day 1. Take the elevator in Tower 1 to the 46th floor.
6:30 AM
  1. Yosemite Foyer
    570 mins
7:30 AM
  1. Grand Ballroom
    510 mins
9:00 AM
  1. Franciscan B/C/D
    180 mins
    Attend 13-minute presentations across several therapeutic areas.
9:15 AM
  1. Franciscan B
    15 mins
    • Gene/Cell Therapy
    Company Description: GelMEDIX is a seed-stage, Harvard/UCLA founded, cell therapy company focused on overcoming the fundamental challenges of current retinal cell therapy technologies to create vision ...
  2. Franciscan C
    15 mins
    • Oncology
    Company Description: Actym Therapeutics has engineered a new drug modality harnessing the power of a genetically modified bacterial vehicle that safely introduces therapeutic payloads to activate the ...
9:30 AM
  1. Franciscan C
    15 mins
    • Oncology
    Allterum Therapeutics is a Fannin-founded biopharmaceutical company targeting the IL-7 pathway for the treatment of patients with Acute Lymphoblastic Leukemia (ALL) and other cancers expressing CD127 ...
  2. Franciscan B
    15 mins
    • CNS/Neurological
    Company Description: LEVERaging RNA regulatory mechanisms to drug the undruggable with RNA-targeted therapeutics. We identify novel target RNA biology and design targeted therapeutics to increase, inh ...
  3. Franciscan D
    15 mins
    • Infectious Diseases
    Company Description: A preclinical stage biotech company in anti-infectives space, developing safer and efficacious biologics therapies against serious invasive fungal infections. Supported by a propr ...
9:45 AM
  1. Franciscan C
    15 mins
    • Oncology
    Pinetree Therapeutics is a biotechnology developing novel medicines to combat drug resistance in oncology and beyond. Pinetree's platform technology AbReptorâ„¢ is a first and best-in-class, transform ...
  2. Franciscan D
    15 mins
    • Regenerative Medicine
    Company Description: Spry Bio, Inc. is a pre-clinical biotechnology company developing Optimized Platelet Therapies (OPTs) for treating osteoarthritis (OA) and other medical conditions characterized b ...
  3. Franciscan B
    15 mins
    • Oncology
    Company Description: We are a biotech company that has been developing new drugs by focusing on the protein degrader field since 2016/2017. About 50 people are working together in Korea, the United St ...
10:00 AM
  1. Franciscan D
    15 mins
    • Ophthalmology
    ViAn Therapeutics is developing an antiangiogenic peptidic drug for topical application in high-impact retinal diseases (DR, DME, AMD). Besides the non-invasive administration, this drug can stabilize ...
  2. Imperial Ballroom
    50 mins
    Since the passage of the Inflation Reduction Act, companies, investors, and patients have raised concerns about how the legislation will impact innovation in the biotech industry. Will there be a decl ...
  3. Franciscan C
    15 mins
    • Oncology
    Breakpoint Therapeutics GmbH is a pre-clinical stage company dedicated to the discovery and development of novel oncology drugs that target the DNA damage response (DDR) in cancer cells.
  4. Franciscan B
    15 mins
    • CNS/Neurological
    Company Description: Monument Tx is a clinical stage neuroscience-specialist drug development company. Taking our cue from oncology, we aim to radically reduce drug development timeframes, and increas ...
10:15 AM
  1. Franciscan D
    15 mins
    • Ophthalmology
    Drusolv Therapeutics is a clinical-stage drug company based in Philadelphia. We are repurposing oral atorvastatin (using a novel formulation) for the new indication of early intervention in age-relate ...
  2. Franciscan B
    15 mins
    • CNS/Neurological
    Scioto Biosciences leverages discovery to improve lives. Good bacteria in our bodies have the potential to promote health and treat disease. Science suggests now that many disorders previously not con ...
  3. Franciscan C
    15 mins
    • Oncology
    Mobilizing endogenous bi-specific Natural-Killer T-like cells that penetrate solid tumors and blood cancers
10:30 AM
  1. Franciscan C
    15 mins
    • Oncology
    Bexion is a clinical stage biopharmaceutical company developing a new generation of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy. The Company's lead ass ...
  2. Franciscan D
    15 mins
    • Ophthalmology
    Caeregen is a breakthrough regenerative medicine therapeutics company targeting neurosensory diseases, with a revolutionary first drug, CTR-107 (Noregen), for vision loss and blindness from retinal ...
  3. Franciscan B
    15 mins
    • CNS/Neurological
    Company Description: Aruna's AB126, a therapeutic exosome, is an innovative neural anti-inflammatory and neuromodulator that naturally crosses the blood-brain-barrier. Using exosomes from neural stem ...
10:45 AM
  1. Franciscan B
    15 mins
    • Gene/Cell Therapy
    Aegle Therapeutics is a clinical stage biotech company with a platform technology focused on rare diseases. Aegle first product, AGLE-102, is a compositive of nanoparticles called extracellular vesicl ...
  2. Franciscan C
    15 mins
    • Oncology
    Biofidelity is a rapidly-growing commercial-stage genomic technology company dedicated to bringing the benefits of precision medicine to patients around the world. ASPYRE®, the first application of o ...
  3. Franciscan D
    15 mins
    • Ophthalmology
    Epion Therapeutics (Epion) is developing innovative treatments for corneal diseases with the goal of saving and improving vision for millions of patients around the world. EpiSmartâ„¢, its transformat ...
11:00 AM
  1. Franciscan B
    15 mins
    • Gene/Cell Therapy
    Coastar Therapeutics is a San Diego based company focusing on systemic gene delivery technology. The company has developed a novel ENHEnS technology that can coat human cell membrane on each individua ...
  2. Imperial Ballroom
    50 mins
    A Nature biotechnology report cited an analysis of the 25 most active VC firms that shows less than 1% of senior level investment teams have partners from underrepresented racial and ethnic groups. Mc ...
  3. Franciscan D
    15 mins
    • Respiratory
    Advagene is a discovery company focuses on immunotherapy and intranasal vaccine for respiratory hypersensitivity and infection. The LTh(αK), intellectual property owned by Advagene, is developed by t ...
  4. Franciscan C
    15 mins
    • Oncology
    Company Description: Cellworks Group, Inc. is a leader in Precision Drug Development and Personalized Therapy Biosimulation. The Cellworks Platform predicts therapy response for individual patients an ...
11:15 AM
  1. Franciscan B
    15 mins
    • Gene/Cell Therapy
    The mission of CDR3 is to develop a curative stem cell gene immunotherapy, delivering chimeric antigen receptors (CARs) or T cell receptors (TCRs) to treat chronic viral infections and virus-associate ...
  2. Franciscan D
    15 mins
    • Respiratory
    Inhalon Biopharma is a clinical-stage biotechnology company developing faster-acting, more effective, self-administered inhaled treatments to address the over $40B worldwide unmet need for patients su ...
  3. Franciscan C
    15 mins
    • Oncology
    Rakuten Medical is a private biotechnology firm that is developing cancer therapies with the ability to target cancer cells and induce immunogenic cell death, using a photoimmunotherapy platform with ...
11:30 AM
  1. Franciscan B
    15 mins
    • Gene/Cell Therapy
    Company Description: Celosia Therapeutics is a late discovery / early pre-clinical phase gene therapy company that is changing the paradigm for treatment for neurodegenerative disease. This is achieve ...
  2. Franciscan D
    15 mins
    • Respiratory
    Company Description: Donovan B. Yeates, Ph.D., Founder and CEO, KAER Biotherapeutics Corporation is introducing a two new game-changing product line, AeroPulsR. This device enables aqueous liquid surf ...
  3. Franciscan C
    15 mins
    • Oncology
    Company Description: Tundra Targeted Therapeutics develops bispecific antibodies to treat difficult cancers. The lead candidate targets leukemia and lymphoma by harnessing and activating a patient's o ...
11:45 AM
  1. Franciscan C
    15 mins
    • Oncology
    Jaguar Health is a commercial stage pharmaceuticals company that develops novel, plant-based, sustainably derived prescription medicines for GI distress. Our Mytesi® (crofelemer) product (tablet) is ...
  2. Franciscan B
    15 mins
    • Gene/Cell Therapy
    Company Description: OmniSpirant was founded by Mr Gerry McCauley, a pharmacist, and inventor of the first-in-class inhaled regenerative gene therapy platform technology (OmniSomes). OmniSpirant ident ...
  3. Franciscan D
    15 mins
    • Cardiovascular
    Company Description: KaloCyte is a pre-clinical biotech therapeutic startup company developing ErythroMer, a bioengineered artificial red blood cell (RBC) substitute that can be freeze-dried for long- ...
12:00 PM
  1. Imperial Ballroom
    50 mins
    Dr. Julia Owens is an experienced biopharmaceutical CEO and board member with a deep commitment to advancing innovative therapies for patients over a 20+ year professional career. She brings a unique ...
  2. Grand Ballroom
    60 mins
1:00 PM
  1. Franciscan B/C/D
    240 mins
    Attend 13-minute presentations across several therapeutic areas.
  2. Imperial Ballroom
    50 mins
    Relative to other highly prevalent diseases such as cancers or cardiovascular disease, companies seeking therapies for neurodegeneration have struggled with drug delivery and biomarker validation insi ...
1:15 PM
  1. Franciscan B
    15 mins
    • Metabolic Diseases
    Zucara Therapeutics Inc. is developing ZT-01, a first-in-class therapeutic to prevent insulin-induced hypoglycemia (low blood sugar) in patients using insulin therapy. ZT-01 is designed to inhibit som ...
  2. Franciscan C
    15 mins
    • Infectious Diseases
    Company Description: Company Name: AMR Therapeutics (AMRTx) Company Description: AMRTx is a pioneering biotechnology firm. We are dedicated to revolutionizing post-antibiotics patient care by developi ...
1:30 PM
  1. Franciscan C
    15 mins
    • Infectious Diseases
    Blue Lake Biotechnology is re-inventing vaccines with a next generation intranasal vaccine vector. Our plug-and-play platform produces vaccines that generate a full spectrum of immune responses to pro ...
  2. Franciscan B
    15 mins
    • Metabolic Diseases
    Company Description: Adge Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of best-in-class therapies for the management of obesity and metabolic syndrome. Adge ...
1:45 PM
  1. Franciscan C
    15 mins
    • Infectious Diseases
    Aeolian Biotech Corp is committed to creating an improved, next generation pneumococcal conjugate vaccine (iPCV22) that is designed to provide best in class coverage for adults.
  2. Franciscan B
    15 mins
    • Metabolic Diseases
    Company Description: Glyscend Therapeutics is a clinical-stage biopharmaceutical company that is reshaping the treatment of metabolic disease with first-in-class oral polymeric drugs that have the pot ...
2:00 PM
  1. Imperial Ballroom
    50 mins
    Last year, Google's AlphaFold project demonstrated it can model more than 200 million molecular 3-D structures, including nearly all known proteins, by applying computational biology and artificial in ...
  2. Franciscan C
    15 mins
    • Infectious Diseases
    Company Description: Baiya Phytopharm Co., Ltd. (Baiya Phytopharm) commenced as a spin off in Bangkok, Thailand in 2018 to a global, clinical phase biopharmaceutical company in 2021. We specialize in ...
2:15 PM
  1. Franciscan B
    15 mins
    • Gene/Cell Therapy
    Garuda Therapeutics seeks to create a world that eliminates the dependency on donor or patient cells for blood stem cell transplants. Our platform technology for generating off-the-shelf, self-renewin ...
  2. Franciscan C
    15 mins
    • Infectious Diseases
    Company Description: Vaxess is an RA Capital-backed, clinical-stage company bringing healthcare out of the clinic with the MIMIX Smart Release patch platform. The MIMIX platform, developed at MIT, use ...
2:30 PM
  1. Franciscan C
    15 mins
    • Inflammation
    Amytrx is a clinical-stage biopharmaceutical company advancing the next generation of new anti-inflammatory peptide therapies for patients suffering from chronic inflammatory diseases. We are a group ...
  2. Franciscan B
    15 mins
    • Gene/Cell Therapy
    Company Description: XyloCor Therapeutics, Inc. is a private, clinical stage biopharmaceutical company developing potential best in class gene therapies to transform outcomes for patients with cardiov ...
2:45 PM
  1. Franciscan B
    15 mins
    • Gene/Cell Therapy
    Company Description: Carina Biotech is a private Australian immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. CAR-T t ...
  2. Franciscan C
    15 mins
    • Inflammation
    Company Description: Serpass Biologics is a Biotech start up established at Arizona State University, Biodesign Inst. We are developing virus-derived immune and coagulation modulating proteins, a new ...
3:00 PM
  1. Imperial Ballroom
    50 mins
    After an 80% decline in IPO volume from the 2021 peak and the Federal Reserve's start of raising interest rates, conditions appear now to be shifting towards stabilizing rates and slowly opening the I ...
  2. Franciscan B
    15 mins
    • Gene/Cell Therapy
    Company Description: Neomics is a cell and gene therapy company innovating adoptive cell therapy to cure cancers and mcDNA to usher new era of genetic medicines. NPB5005-V283 Novel effective anti-BCMA ...
3:15 PM
  1. Franciscan B
    15 mins
    • Gene/Cell Therapy
    Company Description: CellVax Therapeutics is a privately-held clinical-stage company active in research, development, and innovation on human immunodiagnostic and autologous anticancer vaccines, devel ...